OCT Vibrography for Biomechanical Properties of Tissues

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMassachusetts General Hospital

About this trial

The overall goal of this study is to develop OCT Vibrography (aka OCT elastography) as a novel tool for measuring biomechanical properties of human tissues in vivo.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Subjects with history of eye diseases, and previous eye surgeries.

Subjects with diabetes, glaucoma family history

Subjects allergic to anesthetic eyedrop, especially proparacaine

Subjects with severe allergy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Optical imaging of the tissues

    Device

    OCT vibrography

Treatment groups

90 Participants
are divided into 4 treatment groups
Group A: Healthy corneaExperimental treatment 1 intervention
Group B: Healthy skinExperimental treatment 1 intervention
Group C: Healthy gingivaExperimental treatment 1 intervention
Group D: Keratoconus corneaExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.

Frequency and severity of all treatment-related adverse events

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Massachusetts General Hospital

Lead sponsor

Massachusetts Eye and Ear Infirmary

Collaborator